SCHEMBL25517754

SCHEMBL25517754

COP(=O)(O)OCCCNC(C)=O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.47
MAPK1 P28482 1/20 0.47
HIF1A Q16665 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.44
PLA2G2A P14555 2/20 0.42
TSHR P16473 1/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
PAOX Q6QHF9 3/20 0.40
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
ALDH1A1 P00352 1/20 0.40
ADRA1A P35348 1/20 0.39
SAT1 P21673 1/20 0.38
RECQL P46063 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20041842 0.93 KDM4E (0.53) KDM4EMAPK1HIF1AL3MBTL1PLA2G2A
SCHEMBL25517756 0.93 KDM4E (0.53) KDM4EMAPK1HIF1AL3MBTL1PLA2G2A
SCHEMBL13208810 0.89 MTNR1A (0.42) KDM4EMAPK1HIF1AL3MBTL1PLA2G2A
SCHEMBL23451136 0.85 TSHR (0.47) KDM4EMAPK1HIF1APLA2G2ATSHR
SCHEMBL23452878 0.85 KDM4E (0.44) KDM4EMAPK1HIF1APLA2G2ATSHR
SCHEMBL17753875 0.83 KDM4E (0.52) KDM4EMAPK1HIF1AL3MBTL1TSHR
SCHEMBL23442008 0.83 PLA2G2A (0.44) KDM4EMAPK1HIF1APLA2G2ATSHR
SCHEMBL14265137 0.83 PLA2G2A (0.44) KDM4EMAPK1HIF1APLA2G2ATSHR
SCHEMBL16982413 0.80 ALDH1A1 (0.40) KDM4EMAPK1HIF1AL3MBTL1PLA2G2A
SCHEMBL23451009 0.80 PLA2G2A (0.43) KDM4EMAPK1HIF1APLA2G2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023086978-A2 BRANCHED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS DTX PHARMA, INC. (US) 2023-05-19 WO disclosed
WO-2023086979-A1 STAGGERED TRIPLE LIPID-MODIFIED NUCLEIC ACID COMPOUNDS DTX PHARMA, INC. (US) 2023-05-19 WO disclosed